Unknown

Dataset Information

Production of recombinant streptokinase from Streptococcus pyogenes isolate and its potential for thrombolytic therapy.


ABSTRACT:

Objectives

To produce an effective recombinant streptokinase (rSK) from pathogenic Streptococcus pyogenes isolate in yeast, and evaluate its potential for thrombolytic therapy.

Methods

This study was conducted from November 2012 to December 2013 at King Khalid University, Abha, Kingdom of Saudi Arabia (KSA). Throat swabs collected from 45 pharyngitis patients in Asser Central Hospital, Abha, KSA were used to isolate Streptococcus pyogenes. The bacterial DNA was used for amplification of the streptokinase gene (1200 bp). The gene was cloned and in vitro transcribed in an eukaryotic expression vector that was transformed into yeast Pichia pastoris SMD1168, and the rSK protein was purified and tested for its thrombolytic activity.

Results

The Streptococcus pyogenes strai

SUBMITTER: Assiri AS 

PROVIDER: S-EPMC4362161 | biostudies-literature | 2014 Dec

REPOSITORIES: biostudies-literature